Articles from EmeraNova

EmeraNova™, a Phoenix-based medical technology company specializing in advanced tissue restoration technologies, is amplifying its mission to seek out new innovations and bring them to market through the launch of Catalyst. Catalyst, an EmeraNova™ Accelerator, is a four-month accelerator designed for startups at the frontier of tissue restoration and advanced wound care, which will include validation, mentorship, and investment opportunities. Applications are open now.

EmeraNovaTM, the new corporate identity of BioLab Holdings and a medical technology company building an advanced tissue restoration platform, is expanding its tissue preparation and restorative capabilities through a new commercialization collaboration with Hyalomatrix®.

Following yesterday’s milestone launch announcement, EmeraNova™, the new corporate identity of BioLab Holdings and a medical technology company building an advanced tissue restoration platform, has announced a collaboration that will expand its portfolio into an entirely new category and allow it to enter additional care settings. Technology leader Kent Imaging is teaming up with EmeraNova to bring advanced wound imaging to wound care clinics, surgical centers, hospitals and HOPDs.

BioLab Holdings announced today a new, larger mission with the launch of EmeraNova™, a new corporate identity that reflects a broader ambition to advance tissue restoration across specialties, healing phases, and care settings. The launch marks the company’s efforts to build a global platform focused on identifying promising technologies and accelerating their path into clinical practice.